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Верификацијата на квалитативните методи со брзи тестови за детекција на осум дроги кои се 
злоупотребуваат во урината (амфетамини, метамфетамини, барбитурати, кокаин, марихуана, 
3,4-метилендиокси-метамфетамин, метадон и опиати) беше направена со примена на резулта-
тите од оценката од надворешната контрола на квалитетот, врз основа на протоколот за вери-
фикација во нашата лабораторија, кој опфаќа претходно дефинирани критериуми како  што 
се: точноста, сензитивноста и специфичноста на методот. Нашите резултати покажаа дека 
квалитативниот метод за детекција на дрогите кои се злоупотребуваат во урина ги исполнува 
претходно дефинираните критериуми во поглед на сензитивноста, специфичноста и точнос-
та за screening потреби. Постои добро совпаѓање на добиените резултати од наша страна со 
резултатите од надвoрешната контрола на квалитет. Веродостојноста на методот ги исполни 
претходно дефинираните критериуми со исклучок на амфетамините и метамфетаминот (слаба, 
односно никаква). Како заклучок можеме да кажеме дека брзите неинструментални тестови за 
детекција на дроги кои се злоупотребуваат во урината покажаа задоволителни резултати од 
верификацијата и ги исполнија критериумите за соодветната планирана намена во согласност 
со стандардот ISO 15189.
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The verification of the qualitative method with test devices for detection of eight drugs of 
abuse in urine (amphetamines, methamphetamine, barbiturates, benzoylecgonine, marijuana, 
3,4-methylendioxy-methamphetamine, methadone, and opiates) was done using the assessment 
results from External Quality Assessment Scheme according to verification protocol in our 
laboratory, which included predefined performance characteristics such as: accuracy, sensitivity 
and specificity of the method, as well as for method comparison analysis. Our results have shown 
that qualitative methods for detection of drugs of abuse in urine have fulfilled the predefined 
criteria in regard to sensitivity, specificity and accuracy for screening purposes. There was a good 
agreement between the observed results and assessment results. Reliability of the method has 
fulfilled the predefined criteria with the exception for amphetamine and methamphetamine (weak 
and none, respectively). As a conclusion we may say that the rapid non-instrumented test devices for 
detection of drugs of abuse in urine have shown satisfactory verification results and have fulfilled 
the criteria for intended purposes according to the ISO 15189 Standard.
Abstract
ЈАВНО ЗДРАВЈЕ
 PUBLIC HEALTH
АРХИВИ НА ЈАВНОТО ЗДРАВЈЕ
32
Introduction
Laboratory medicine practice, as a part 
of the health care system, is regulated by 
the Law on Health Care of the Republic 
of Macedonia. The most recent chang-
es of the Law, in regard to Laboratory 
Medicine, were made in order to provide 
a better diagnosis while maintaining 
standard quality credentials, where the 
standardisation of biochemical laborato-
ries according to ISO 15189 Standard and 
their mandatory participation in EQAS 
(External Quality Assessment Scheme) 
or in External Quality Control (EQC) 
became obligatory1. Towards initial ac-
creditation phase according to ISO 15189 
Standard, the verification of the methods 
is required in order to decide whether or 
not the method is suitable for intended 
purposes of the Standard and to elimi-
nate errors in the test results2,3. In addi-
tion to verification of quantitative tests, 
veri fi ca tion of the qualitative tests (such 
as the verification of non-instrumented 
qualitative method for drugs of abuse in 
urine) has to be performed before their 
implementation in the laboratory work3. 
Those methods have only two possible 
results - “positive” or “negative”, and the 
obtained results have to be confirmed by 
gas chromatography-mass spectrometry. 
Performance charact eristics and accep-
tance criteria of these methods are not 
always detailed and every laboratory has 
to choose the most suitable verification 
protocol.  Therefore, this study was de-
signed to verify the qualitative method 
for drugs of abuse in urine according to 
the requirements of the Standard, us-
ing alternative approaches - assessment 
results from the five-year participation 
in EQAS (Instand e.V.Gesellschaft zur 
Förderung der Qualitätssicherung in 
medizinischen Laboratorien e.V.) 3,4.
Material and methods
The verification protocol of our labora-
tory, based on the Guidelines for the val-
idation and verification of quantitative 
and qualitative test methods, comprised 
reproducibility testing of minimum 10 
samples from each category (positive and 
negative)5,6. The reported and the obtained 
test results were used for calculation of 
accuracy, sensitivity and specificity of the 
method, as well as for the method com-
parison analysis (agreement between the 
methods and data-k-coefficient)7,8 accord-
ing to predefined performance character-
istics. The predefined acceptable criteria 
for these tests for our laboratory were:
• The obtained data should meet the pre-
defined performance charac teristics 
and the claims of the manufacturer in 
regard to sensitivity and specificity and 
the combined sensitivity and specifici-
ty should be in total = 170;
• The test should have total accuracy of 
minimum 80%;
• The agreement between the meth-
ods (semi-qualitative method and gas 
chromatography-mass spectrometry) 
should be 80% and the value of kappa 
(k) minimum of 0.6-0.798.
For verification of the method, non-in-
strumented test devices (cassettes or 
strips) (IVD products) manufactured 
by Nova, Dima, Human, IND Diagnos-
tic Inc (IND) with CE conformity mark-
ing, were used. The devices were stored 
at room temperature, and used with-
in the expiration date for detection of 
amphetamine,methamphetamine,bar-
bitu rates, benzoylecgonine, 11-nor-del-
ta-9-THC-COOH(marijuana),3,4-meth-
ylendioxy-methamphetamine(MDMA) 
(ecstasy), methadone, and opiates in the 
assessment samples. These tests share the 
common immune-assay based test princi-
ple of competitive binding only providing 
preliminary results that must be confirmed 
by more specific quantitative methods (e.g. 
GC/MS)9. The external quality assessment 
specimens were transported and stored at 
+40C prior to testing, dissolved in the prop-
er volume of double-distilled water and 
brought to a room temperature prior to 
testing. The urine samples were tested in 
triplicate within specified time limits and 
the test results were recorded separately 
as one of two options: negative or posi-
tive. The results were reported within the 
deadline dates, and obtained quantitative 
assessment results were used for method 
verification according to the predefined 
criteria. The sensitivity and specificity, 
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positive and negative predictive values, 
accuracy, and the ratio of agreement be-
tween the methods were calculated using 
assessment results as follows:
• Sensitivity (%): Number of true posi-
tives/ (Number of true positives + Num-
ber of false negatives multiplied with 
100);
• Specificity (%): Number of true nega-
tives/ (Number of true negatives + Num-
ber of false positives multiplied with 
100);
• Positive predictive value (%) (PPV): 
Number of true positives/ (Number of 
true positives + Number of false posi-
tives multiplied with 100);
• Negative predictive value (%) (NPV): 
Number of true negatives/ (Number of 
true negatives + Number of false nega-
tives multiplied with 100);
• Accuracy (%): (Number of true positives 
+ Number of true negatives) / (Num-
ber of true positives + Number of false 
positives + Number of true negatives + 
Number of false negatives) multiplied 
with 10010.
•  Ratio of (agreement%): Number of 
agreement between the reported and 
assessment results/ number of sam-
ples multiplied with 100;
• Cohen’s kappa coefficient (k) (for reli-
ability of the method) was calculated 
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according to the following formula:
Where Pr (a) is actual observed agreement and Pr (e) is expected agreement calculated 
according to the following formula:
•  cm1 represents column 1 marginal;
•  cm2 represents column 2 marginal;
•  rm1 represents row 1 marginal;
• rm2 represents row 2 marginal;
• n represents the number of observa-
tion8.
The performance characteristics of non-in-
strumented method for drugs of abuse in 
urine are presented in Table 1. The highest 
diagnostic sensitivity (100%) was obtained 
for detection of methamphetamine, ben-
zoylecgonine and MDMA and the lowest 
for barbiturates (71%). 
The obtained diagnostic sensitivity for 
barbiturates was lower than the pre-
defined one, which might be due to the 
borderline assessment sample concen-
tration.  The highest diagnostic specific-
ity was obtained for methadone and opi-
ates (93%) and the lowest for marijuana 
(78%) (Table 1).  
The highest positive predictive value 
(PPV) (%) was obtained for benzoylecgo-
nine (91%) and the lowest for metham-
phetamine (67%). Positive predictive val-
ues for other tested drugs were between 
80% (amphetamines) and 86% (for opi-
ates). Negative predictive values were be-
tween 71% (for barbiturates) and 100% (for 
methamphetamine, benzoylecgonine and 
MDMA) (Table 1). 
The highest overall accuracy was ob-
served for benzoylecgonine (95%) and the 
lowest for barbiturates (77%) (Table 1). 
Results
Where:
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Table 1.  Verification of the qualitative method for detection of drugs of abuse in urine
Table 2.  Statistical results of the reliability of qualitative method(s) for drugs of abuse in urine 
In order to measure the reliability of the 
method, the observed agreement and Co-
hen’s kappa (k) values were calculated (Ta-
ble 2). The observed agreement was from 
70% (methamphetamine) to 95% (benzo-
ylecgonine and methadone respectively) 
meaning that 5-30% of the reported data 
were incorrect. Regarding our predefined 
criteria the percent of observed agree-
ment was acceptable for screening pur-
poses with the exception for methamphet-
amine and barbiturates. Nevertheless, this 
includes the expected agreement, which 
is the agreement by chance alone (Pe) and 
the agreement beyond chance. Due to 
the limitation of the simple proportion of 
agreement, the Cohen’s kappa as a mea-
sure of agreement between two methods 
was calculated and the data are presented 
in Table 2.
Narcotic drug in urine Cut-off ` Sensitivity Specificity PPV  NPV  Accuracy
   ng/ml      (%)      (%) (% )  (%)      (%)
Amphetamines 1000      80        91  80  91      87
Methamphetamine 1000      100     89  67  100      91
Barbiturates 300      71      83  83  71      77
Benzoylecgonine 300      100     91  91  100      95
Marijuana (THC) 50      92      78  78  90      83
MDMA 500      100     91  83  100      94
Methadone 300      85      93  85  93      91
Opiates 2000      85      93  86  93      91
Abbreviations: PPV, positive predictive value: NPV, negative predictive value
Amphetamines 1000      85     0.46       Weak        15-35     1 Almost       82-100
         Perfect
Methamphetamine 1000      70     0            None          0-4 0 None 0-4
Barbiturates 300      75     0.7        Moderate   35-63 0.5 Weak 15-35
Benzoylecgonine 300      95     0.8        Strong        64-81 0.9 Strong 64-81
Marijuana (THC) 50      80     0.6        Moderate   35-63 0.7 Moderate 35-63
MDMA 500      93     0.9        Strong        64-81 0.7 Moderate 35-63
Methadone 300      95  > 0.9        Almost       82-100 0.9 Strong 64-81
           Perfect 
Opiates 2000      90     0.8        Strong       64-81 0.8 Strong 64-81
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*k- Cohen’s kappa coefficient (k) (for reliability of the method)
Cohen’s kappa for benzoylecgonine, metha-
done and opiates has shown strong to almost 
perfect level of agreement for both, positive 
and negative samples. Although the observed 
agreement for marijuana was at the accept-
able level, Cohen’s kappa showed moderate 
agreement between the methods, similar to 
barbiturates. There was no agreement for 
methamphetamine and only a week one for 
amphetamines.
Vol.10 No.1 2018
35
Discussion
The results obtained for the performance 
characteristics of the test devices were in 
agreement with the predefined acceptable 
criteria for intended purposes (screening) 
in our laboratory, as well as with those de-
clared by the manufacturers.
The intended use of the tests was for 
screening purposes meaning that the per-
formance goal for the screening proce-
dure can be a very high sensitivity, which 
should be confirmed by a gold standard 
method(gas chromatography-mass spec-
trometry).. Both, percent agreement and 
kappa have strengths and limitations10,11. 
The percent agreement statistics is easily 
calculated and directly interpretable. Its 
key limitation is that it does not take into 
account the possibility that raters guessed 
on scores, and may overestimate the true 
agreement among raters. The kappa takes 
into account the possibility of guessing, 
but the assumptions it makes about rat-
er independence and other factors are 
not well supported, and thus it may low-
er the estimate of agreement excessively. 
Low levels of interrater reliability are not 
acceptable in health care or in clinical re-
search, especially when the results might 
imply legal procedures. We think that the 
best advice for laboratories is to calculate 
both percent agreement and kappa. It will 
be of a great importance for the beneficia-
ries to be aware of the limitations of the 
qualitative methods for drugs of abuse in 
urine.
Conclusions 
In conclusion, the parameters tested for 
the verification of the qualitative method 
for drugs of abuse in urine have fulfilled 
the predefined acceptance criteria for di-
agnostic sensitivity and specificity and for 
accuracy. In regard to reliability, the qual-
itative methods for drugs of abuse have 
shown satisfactory results for the screen-
ing purposes of the tests with exclusion 
of methamphetamine. We may conclude 
that the verification results have fulfilled 
the predefined criteria and the Standard 
requirements and can be introduced as 
screening methods in our laboratory. 
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